As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...

Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Let's take a detailed look at the dangers of using Ozempic: Reports link Ozempic to blindness and NAIOD, making it a risky ...

Following acceptance of a protocol amendment, Rhythm expects to begin dosing patients with acquired HO in Part C of the Phase ...

In the pursuit of optimal health and wellness, hydration often takes center stage. Many individuals, particularly seniors, ...

Medicare has announced the expansion of coverage for Eli Lilly’s Zepbound, a breakthrough drug in the treatment of autoimmune ...

Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...

Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

We asked the professionals for the lowdown on getting rid of submental fat (double chin) with in-office and at-home treatments.